News

Both companies will co-market Invitrogen's assay technology with PamGene's portfolio of microarray-based Nuclear Hormone Receptor screening tools.

Collaboration to support proof-of-concept studies of novel disease targets and therapeutic antibodies.

The partnerships will enable GE Healthcare to further extend its offering of cellular analysis and automation solutions for the IN Cell Analyzer platform.

The award has been granted for a three-year project aims to accelerate Galapagos' rheumatoid arthritis programs through clinical Proof of Concept in man.

Prescription drugs now used to treat human immunodeficiency virus infection in adults may prevent the vaginal transmission of HIV, UT Southwestern researchers have found.

Epigenomics gains rights to DxS’ technology for R&D use and research kits, as well as an option to expand the license to the in vitro diagnostics field.

The patent, entitled “Production of ssDNA in vivo,” claims both compositions and methods for using the single stranded DNA expression vectors.

In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors.

The system will be used to examine genes for diabetes-related traits and to investigate genetic variants affecting skeletal muscle hypertrophy.

ARTES will apply its Hansenula technology platform and know-how to the generation of production cell lines, analytical assay development, and lab-scale fermentation.